Top Medical News
Glaucoma tied to increased risk of Alzheimer's, related dementias
11 hours ago
Individuals with glaucoma, particular those diagnosed at older ages, are prone to developing Alzheimer’s disease (AD), vascular dementia (VaD), and all-cause dementia (ACD), reports a study.
Early-onset oculomotor neuropathy ups dementia risk
Adults who develop ocular motor cranial neuropathy (OMCN), particularly at a younger age, are at greater risk of having dementia, reveals a study.
People with vision impairment prone to psychosocial problems
2 days ago
Vision impairment appears to contribute to several psychosocial outcomes, including depression, anxiety, and social isolation, according to a study.
Diabetic retinopathy predicts heart problems in type 1 diabetes
2 days ago
Among individuals with type 1 diabetes, diabetic retinopathy is independently associated with prevalent and incident cardiovascular disease, as reported in a study.
Eye diseases spell increased risk of falls, fractures
6 days ago
People with cataract, age-related macular degeneration (AMD), and/or glaucoma are at heightened risk of both falls or fractures, as shown in a study.
Acetylcholinesterase inhibitors may have potential protective effect against AMD
22 Feb 2024
In the treatment of individuals with Alzheimer’s disease, acetylcholinesterase inhibitors (AChEIs) appear to confer a small reduction in the risk of age-related macular degeneration (AMD), as shown in a study.
Recombinant zoster vaccine exposure ups risk of ophthalmic zoster recurrence
20 Feb 2024
For people with a history of herpes zoster ophthalmicus (HZO), the likelihood of HZO recurrence increases upon exposure to recombinant zoster vaccine, as shown in a retrospective study.
Special Reports
No increased ophthalmic risk with roxadustat treatment in DD CKD-related anaemia
Roshini Claire Anthony, 28 Jun 2020

Roxadustat treatment for anaemia in patients with dialysis-dependent chronic kidney disease (DD CKD) does not come with an increased risk of ophthalmic abnormalities, according to a phase III trial conducted in Japan.

Conference Reports
AI raises the bar for diagnosing severe TED
Elvira Manzano, 23 May 2023
Artificial intelligence (AI) can help diagnose thyroid eye disease (TED) and assess for severity by analysing CT scans, reports an expert at ARVO 2023.
Switching to brolucizumab improves visual acuity in nAMD
Elvira Manzano, 11 May 2023
Switching from other anti-VEGF* agents to brolucizumab only helps improve visual acuity and reduces disease activity in patients with neovascular (wet) age-related macular degeneration (nAMD)